Page last updated: 2024-10-29

iodixanol and Hepatitis C

iodixanol has been researched along with Hepatitis C in 1 studies

iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.

Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vercauteren, K1
Van Den Eede, N1
Mesalam, AA1
Belouzard, S1
Catanese, MT1
Bankwitz, D1
Wong-Staal, F1
Cortese, R1
Dubuisson, J1
Rice, CM1
Pietschmann, T1
Leroux-Roels, G1
Nicosia, A1
Meuleman, P1

Other Studies

1 other study available for iodixanol and Hepatitis C

ArticleYear
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents.
    Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:5

    Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Hepacivirus; Hepatitis C; Humans; Lipoproteins; M

2014